Transcript
The cost of living is skyrocketing across Canada and the health of Canadians is feeling the impact.
According to the Canadian Cancer Society, nearly a quarter of Canadians in 2024 reported splitting pills, skipping doses or not refilling a prescription due to cost.
They report that 28 per cent of Canadians have had to dig into their grocery or housing budgets to afford their medications.
Not following the instructions that accompany prescriptions can lead to increased hospitalizations, especially for chronic conditions that require careful management.
Attempting to address the issue, NDP leader Jagmeet Singh has been pushing a new pharmacare act, Bill C-64.
Not everyone is happy with the proposal though. Facing opposition from some government members and provinces, the future of the act is uncertain.
The goals of the act are: Improving the accessibility and affordability of prescription drugs and related products, the appropriate use of such drugs and products, the development of a national formulary of essential prescription drugs and related products, and establishing a national bulk purchasing strategy.
Bill C-64 hopes to eventually cover all necessary medications and devices. But to start, it’ll cover the cost of some contraception and diabetes medications and devices.
Estimating it will help 13 million Canadians, the pharmacare act is trying to remove the main barrier to access: cost.
An admirable goal, it’ll take a lot of preparation and planning before it can be implemented.
The act states that if approved, the Minister of Health, Mark Holland, must create a committee of experts to make recommendations on the implementation of a national, universal, single-payer pharmacare program within 30 days.
He will also have to work with the Canadian Drug Agency who will determine which drugs and devices should be covered under the act, weigh in on purchasing strategies, and define appropriate use of prescription drugs that can be applied around the country.
But executing the plan across Canada might never happen. Alberta and Quebec have already made it known they’d like to opt out of the act and want to invest the money into their own drug plans instead.
Many other provinces are on the fence, waiting for more information before committing either way.
Implementing this act would eventually replace public and private health insurance plans.
Instead, there would be a $5 copayment for name brand drugs. Some populations, like Indigenous Peoples, would be exempt from this cost.
As of now, Pharmacare Act, Bill C-64 is still in the early stages. It has not been approved and there is no timeline for implementation or accomplishing the goals it sets out.
Subscribe to The Health Insider for updates on the proposed Pharmacare Act and on other issues that impact the state of Canadian healthcare.
Sources:
~ Read more from The Health Insider ~
- Protecting Canada’s Kids: The Hidden Risk in Your Child’s Favourite Cartoon Snacks
A Canadian report finds many kids’ snacks with cartoon characters are high in sugar, sodium or fat, raising concerns about food marketing to children. - At-Home Sperm Testing: As Accurate As In-Clinic?Skip the clinic. Learn how Canadian mail-in kits bypass the “one-hour rule” with 99% accuracy and which provincial credits cover the cost.
- Endometriosis and the Immune System: What New Research Is ShowingNew research suggests people with endometriosis may face higher odds of autoimmune disease. Here’s what scientists know so far.
- Beyond Red & Green: New Tech for Colour BlindnessOver 1.5 million Canadians live with colour blindness. Discover the science, daily challenges, and the high-tech tools changing how they see.
- Health Canada Approves Ozempic to Reduce Heart Attack and Stroke RiskHealth Canada expands Ozempic approval to include reducing the risk of heart attacks and strokes in adults with type 2 diabetes and heart or kidney disease.
- Heart Health Starts in Childhood: Paediatricians Calling for Universal Cholesterol Screening for KidsThe Canadian Paediatric Society recommends lipid screening for children ages 2–10 to identify heart risks and genetic conditions like FH early.
The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment. To read about our editorial review process click here.
